Short-term efficacy of tildrakizumab on difficult-to-treat areas: a real-world experience.
Cacciapuoti S, Potestio L, Gallo L, Musumeci ML, Caldarola G, D'Amico D, Caudullo F, Papaianni V, De Simone C, Peris K, Megna M.
Cacciapuoti S, et al. Among authors: potestio l.
Int J Dermatol. 2024 Jul 12. doi: 10.1111/ijd.17368. Online ahead of print.
Int J Dermatol. 2024.
PMID: 38997809